SlideShare uma empresa Scribd logo
1 de 24
EVALUTION AND SCREENING OF
ANTIFERTILITY AGENT
Presented by-Komal Dobariya
Department Of Pharmacology
MPS-1
L.M College Of Pharmacy
EVALUTION METHOD OF ANTIFERTILITY AGENT :
1. Estimation of sex hormones
2. Assessment of sperm viability and morphology
3. Assessment of sperm motility and count
4. Mating trial test
5. Body and sex organ weights
6. Quantification of fructose in seminal vesicle
7. Abortifacient activity (Anti-implantation activity)
8. Post-coital anti-fertility activity (Pre-implantation activity)
9. Effect on estrous cycle
10. Anti-estrogenic activity
11.Anti- gonadotrophic effect
12.Histological analysis
13.Measurement of some biochemical and blood parameters
14.Determination of testicular and serum cholesterol (Chod
PAP method)
15.Determination of total protein
1.ESTIMATION OF SEX HORMONES :
• Blood samples were collected from rats for estimations of
serum levels of sex hormones.
• Sera were separated into clean bottles, stored frozen and used
within 12 h of preparation for the estimation of testosterone,
estrogen level, prolactin, follicle stimulating hormone (FSH) and
luteinizing hormone (LH).
2. ASSESSMENT OF SPERM MOTILITY AND COUNT :
• Progressive motility was tested immediately. The right caudal
epididymis was incised and semen was squeezed on a pre-warmed
slide.
• Two drops of warm 2.9% sodium citrate was added to semen and
mixed by a cover-slip. The percentage of progressive sperm motility
was evaluated visually at 400 magnification.
• Motility estimates were performed from three different fields in each
sample. The mean of the three successive estimations was used as
the final motility score.
• For sperm count, the left caudal epididymis was incised and semen
that oozed was quickly sucked into a red blood pipette to the 0.5
mark, and then diluted with warm normal saline up to the 100 mark.
A drop of the semen mixture was placed on the Neuberger counting
chamber and viewed under the magnification of ×40. The total
numbers of sperm cells were counted and expressed as 106/ml.
3. ASSESSMENT OF SPERM VIABILITY AND
MORPHOLOGY :
• A viability study (percentage of live spermatozoa) was done using
eosin/ligroin stain. A drop of semen was squeezed onto a microscope
slide and two drops of the stain were added.
• Thin smears were then prepared and observed under a light
microscope at 100 magnification. Viable sperm remained colorless
while non-viable sperm stained red.
• The stained and the unstained sperm cells were counted using
40/100 microscope objectives and an average value for each was
recorded from which percentage viability was calculated.
• To determine the percentage of morphologically abnormal
spermatozoa, the slides stained with eosin–ligroin (5 slides/rat)
viewed under a light microscope at 100 magnifications.
4. MATING TRIAL TEST :
• Mating trial test of male rats was done, 5 d before the termination of
the experiment.
• Each male rat was cohabitated overnight with protestors females in a
ratio of 1:2 and housed in a single cage. Positive mating was
confirmed by presence of sperm and vaginal plug in the vaginal
smear the following morning. Each sperm positive female was kept
under observation and the resultant pregnancies were noted, when
dam gave birth. The following reproductive parameters were then
computed:
 Mating success % = number mated/number paired × 10;
 Fertility success % = number pregnant/number paired × 100;
 Fertility index = number pregnant/number mated × 100
5. BODY AND SEX ORGAN WEIGHTS :
• The initial and final body weights of the animals were recorded. The
testes, epididymides, seminal vesicle and ventral prostate were
dissected out, freed from adherent tissues and blood, and weighed to
the nearest milligram.
• Organ weights were reported as relative weights (organ weight/body
weight × 100).
6. QUANTIFICATION OF FRUCTOSE IN SEMINAL
VESICLE :
• For fructose quantification, seminal vesicular homogenate was
prepared at a tissue concentration of 50 mg/ml.
• The supernatant (seminal plasma) was deproteinized by adding 50
mL of zinc sulfate and sodium hydroxide to make a total dilution of
seminal plasma 1:16, followed by centrifugation at 2500 rpm for 15
min.
• For fructose measurement, 200 mL of clear seminal plasma was used
and the optical density of standard and samples were measured
against blank at 470 nm.
• The concentration of fructose was obtained by plotting the value in
standard curve and the value expressed in the unit of mmol/mL of
seminal plasma.
7. ABORTIFACIENT ACTIVITY (ANTI-IMPLANTATION
ACTIVITY) :
• The plant extracts were tested in female albino rats for abortifacient
activity. The vaginal smears of caged female rats of known fertility
were monitored daily. Unstained material was observed under a light
microscope.
• The proportion among the cells observed was used for the
determination of the estrous cycle phases.
• Female rats were caged with males of proven fertility in the ratio of
2:1, in the evening of proestrous and examined the following day for
the evidence of copulation.
• Rats exhibiting thick clumps of spermatozoa in their vaginal smears
were separated and that day was designated as day one of
pregnancy. These rats were randomly distributed into four groups, a
control group and three experimental groups of six animals each.
Group I received vehicle only and served as control.
• Groups II, III, and IV received different extracts. On the 10th day of
pregnancy the animals were laparotomies under light ether
anesthesia using sterile conditions. The two horns of uteri were
examined to determine the implantation sites.
• Thereafter the abdominal wound was sutured in layers. Post
operational care was taken to avoid any infection. The extract to
be tested were then fed to operated pregnant rats, specified by an
intragastric soft rubber catheter from day 11 up to the 15th day
of pregnancy. The animals were allowed to go to full term. After
delivery the pups were counted and the antifertility activity of
extract was evaluated. Litters were examined for any malformation.
 Percentage abortifacient activity = number of resorptions/number
of corpus luteum × 100
8. POST-COITAL ANTIFERTILITY ACTIVITY (PRE
IMPLANTATION ACTIVITY) :
• The anti-implantation activity is expressed as the percentage
of animals showing absence of implantations in uteri when
laparotomised on day 10 of pregnancy.
• Vaginal smears from each rat were monitored daily and the rats with
normal estrous cycle were selected. Rats found in proestrus phase of
cycle were caged with males of proven fertility, in the ratio 2:1 and
examined the following morning for evidence of copulation.
• Rats exhibiting thick clumps of spermatozoa in their vaginal
smears were separated and that day was designated as day 1 of
pregnancy and those rats were divided into five groups containing six
rats in each group.
• The extract was administered from day 1–7 of pregnancy. The
powdered drug was also administered from day 1–7 of pregnancy.
• Control rats received the vehicle (distilled water).
• On day 25, laparotomy was performed under light ether anesthesia
and semisterile conditions. The uteri were examined to determine
the number of implantation sites and no of corpora luteagraviditis .
 Frequency of pre-implantation losses =
missing no. of implants(corpora lutea implants) × 100.
no. of corpora lutea
9. EFFECT ON ESTROUS CYCLE :
• The female animals were artificially brought into estrus phase (heat)
by administering either suspension of ethinyl estradiol orally at the
dose of 100 mg/animal 48 h prior to the pairing and S.c.
administration of progesterone at the dose of 1 mg/animal 6 h before
the experiment or alternatively by the sequential administration of
estradiol benzoate (10 mg/100 g body weight) and progesterone (0.5
mg/100 g body weight) through subcutaneous injections, 48 and 4 h
respectively.
• Estrous cycle was determined between 8 am and 10 am using
vaginal smear method.
• Vaginal secretion was collected with a plastic pipette with 10 mL of
normal saline.
• The vagina was flushed three times with the pipette and the vaginal
fluid was placed on a glass slide.
• Different slides were used for each animal.
• The unstained secretion was observed under a light microscope.
• After confirmation of regular four day cycle for 2 weeks the animals
were selected for study and divided into six groups and treated with
test drugs.
• The effect of test drugs on the estrous cycle was monitored for 28 d .
10. ANTIESTROGENIC ACTIVITY :
• All the rats were ovariectomized by the same methods described in
previous procedure and the weight of the ovaries were recorded. The
ovariectomized rats were randomly taken and divided in thirteen
groups. Except control, other groups were administered with
different doses of estradiol (0.1 mg/rat and 1.0 mg/rat) and followed
by test compounds respectively for 4 consecutive days.
• On eleventh day, the rats were anaesthetized using ketamine (60
mg/kg, i.p.) and the remaining right sided ovaries were dissected out
from all the animals.
• Properly cleaned, dries and their respective weights were recorded.
• The ovaries weight variations prior to and after treatment with
extracts were calculated.
• Percentage inhibition of ovarian weight was calculated using the
following equation:
 Percentage inhibition in ovarian weight = [1 − (XE − C)]/E− C × 100.
- Where, C = mean ovarian weight from rats treated with vehicle,
E = estradiol and
XE = the mean ovarian weight of rats treated with extract and
estradiol
11. ANTIGONADOTROPHIC EFFECT :
• Female rats were studied for 5 consecutive normal estrus
cycles by vaginal smear method.
• The rats were anaesthetized using ketamine (60 mg/kg) pretreated
with atropine (1 mg/mL) and left side ovariectomy was performed.
• Left ovary was dissected out carefully from surrounding fatty tissue
and dried by soaking on filter paper and weighed.
• The ovariectomized rats were divided into six groups and treated.
• On 12th day after treatment, the remaining right ovaries of all rats
properly dissected out using same anesthetic condition.
• Cleaned, dried and their respective weights were recorded and
percentage increase in ovarian weight compared with weight of the
left ovaries were calculated.
• Percentage increase in the weights of ovary was calculated using the
formula.
 Percentage increase in ovarian weight = (weight of right ovary −
weight of left ovary)/weight of left ovary × 100.
12. HISTOLOGICAL ANALYSIS :
• Testes and uteri were carefully dissected out following abdominal
incision from male and female rats respectively and fixed in 10%
normal-saline and processed routinely for paraffin embedding.
• Sections of 5 mm from both were obtained with rotary microtome,
stained with Hematoxylin and Eosin Stalin (H/E) respectively and
observed under a light microscope .
13. MEASUREMENT OF SOME BIOCHEMICAL
AND BLOOD PARAMETERS :
• Blood samples were collected from the heart of each rat at the
time of scarification into non-heparinized and heparinized tubes.
• Serum aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphates, creatinine and urea in addition to red
blood cell (RBC) count, total leucocytic count (TLC),hemoglobin (Hb)
concentration, packed cell volume (PCV),cholesterol and total
proteins were determined by standard methods .
14. DETERMINATION OF TESTICULAR AND
SERUM CHOLESTEROL (CHOD PAP METHOD)
• Cholesterol is the precursor in the synthesis of many physiologically
important steroids such as bile acids, steroid hormones and vitamin D
and its requirement for normal sexual activity has been well
established.
• Testicular and serum cholesterol concentrations may be determined
by the Chod–PAP method as briefly, 0.02 cm3 of the working reagent
and the absorbance of the resulting mixture is read after 5 min at 546
nm .
15. DETERMINATION OF TOTAL PROTEIN :
• A timed rate biuret method was used to measure the concentration
of total protein in serum or plasma.
• Proteins in the sample combined with the reagent producing alkaline
copper-protein chelate.
• The rate change in absorbance was monitored by a detector
at 545 nm.
• The observed rate of chelate formation is directly proportional to the
total protein concentration in the sample.
REFERENCE :
• Article journal homepage: www.jadweb.org
• http://www.wikipedia .com
screening of anti-fertility agent

Mais conteúdo relacionado

Mais procurados

Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPDJaineel Dharod
 
Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugsDipanjaliKamthe
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methodsmohamed abusalih
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergicsPrajitha p
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsAbin Joy
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsHimikaRathi
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agentsKanthlal SK
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugsPrafulla Tiwari
 
Limitations of animal models part 1
Limitations of animal models part 1  Limitations of animal models part 1
Limitations of animal models part 1 Manohar Kuppala
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsPrajitha p
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugsMy_VivJaan
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugsBindu Pulugurtha
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drugRajeshwar Yadav
 
Drug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agentsDrug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agentsDr. Abhishek Vyas
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malikVikasMalik68
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsShubham Kolge
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugsDHINESHKUMAR V
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agentSONALPANDE5
 

Mais procurados (20)

Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPD
 
Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugs
 
Limitations of animal models part 1
Limitations of animal models part 1  Limitations of animal models part 1
Limitations of animal models part 1
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agents
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugs
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
 
Drug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agentsDrug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agents
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 

Semelhante a screening of anti-fertility agent

In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityswapniltirmanwar
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshakahkesha samshad
 
Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsAkanksha William
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtsujitha12341
 
Antifertility screening
Antifertility screening Antifertility screening
Antifertility screening Prerna Singh
 
In vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsIn vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsAdarsh Patil
 
Fertility and antifertility screening
Fertility and antifertility screeningFertility and antifertility screening
Fertility and antifertility screeningnazuk sharma
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicologyAanchal46
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxPraveen kumar S
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelinesR Nadaf
 
Presentation by neha jain on aspirin induced alterations on liver and kidney
Presentation by neha jain on aspirin induced alterations on liver and kidneyPresentation by neha jain on aspirin induced alterations on liver and kidney
Presentation by neha jain on aspirin induced alterations on liver and kidneyneha jain
 
4.areca catechu in male rats
4.areca catechu in male rats4.areca catechu in male rats
4.areca catechu in male ratsrahma27aulia
 
IBMX part I -rabbit reproduction Theriogenology 2010 (1)
IBMX part I -rabbit reproduction Theriogenology 2010 (1)IBMX part I -rabbit reproduction Theriogenology 2010 (1)
IBMX part I -rabbit reproduction Theriogenology 2010 (1)ELENI FOTOPOULOU
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfVISHALJADHAV100
 

Semelhante a screening of anti-fertility agent (20)

In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activity
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkesha
 
Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agents
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointt
 
Antifertility screening
Antifertility screening Antifertility screening
Antifertility screening
 
Semen analysis or seminal fluid analysis
Semen analysis or seminal fluid analysisSemen analysis or seminal fluid analysis
Semen analysis or seminal fluid analysis
 
In vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsIn vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agents
 
Fertility and antifertility screening
Fertility and antifertility screeningFertility and antifertility screening
Fertility and antifertility screening
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptx
 
Ppt on antifertility
Ppt on antifertilityPpt on antifertility
Ppt on antifertility
 
Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
 
SUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITYSUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITY
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelines
 
Presentation by neha jain on aspirin induced alterations on liver and kidney
Presentation by neha jain on aspirin induced alterations on liver and kidneyPresentation by neha jain on aspirin induced alterations on liver and kidney
Presentation by neha jain on aspirin induced alterations on liver and kidney
 
articulo Articulo
articulo Articuloarticulo Articulo
articulo Articulo
 
4.areca catechu in male rats
4.areca catechu in male rats4.areca catechu in male rats
4.areca catechu in male rats
 
Bott et al 2006
Bott et al 2006Bott et al 2006
Bott et al 2006
 
IBMX part I -rabbit reproduction Theriogenology 2010 (1)
IBMX part I -rabbit reproduction Theriogenology 2010 (1)IBMX part I -rabbit reproduction Theriogenology 2010 (1)
IBMX part I -rabbit reproduction Theriogenology 2010 (1)
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
 

Mais de Jaineel Dharod

Expectorants and anti tussives
Expectorants and anti tussivesExpectorants and anti tussives
Expectorants and anti tussivesJaineel Dharod
 
Bones and skeletal system
Bones and skeletal systemBones and skeletal system
Bones and skeletal systemJaineel Dharod
 
Blood pressure mechanism
Blood pressure mechanismBlood pressure mechanism
Blood pressure mechanismJaineel Dharod
 
Blood vessels and circulation
Blood vessels and circulationBlood vessels and circulation
Blood vessels and circulationJaineel Dharod
 
Atherosclerosis Pathophysiology
Atherosclerosis PathophysiologyAtherosclerosis Pathophysiology
Atherosclerosis PathophysiologyJaineel Dharod
 
Introduction and scope of anatomy and physiology
Introduction and scope of anatomy and physiologyIntroduction and scope of anatomy and physiology
Introduction and scope of anatomy and physiologyJaineel Dharod
 
Scope of anatomy and physiology
Scope of anatomy and physiologyScope of anatomy and physiology
Scope of anatomy and physiologyJaineel Dharod
 
Atherosclerosis Pathophysiology
Atherosclerosis PathophysiologyAtherosclerosis Pathophysiology
Atherosclerosis PathophysiologyJaineel Dharod
 
Cell injury pathophysiology
Cell injury pathophysiologyCell injury pathophysiology
Cell injury pathophysiologyJaineel Dharod
 
Pathophysiology of Inflammation
Pathophysiology of InflammationPathophysiology of Inflammation
Pathophysiology of InflammationJaineel Dharod
 

Mais de Jaineel Dharod (20)

Expectorants and anti tussives
Expectorants and anti tussivesExpectorants and anti tussives
Expectorants and anti tussives
 
Integumentary system
Integumentary systemIntegumentary system
Integumentary system
 
Bones and skeletal system
Bones and skeletal systemBones and skeletal system
Bones and skeletal system
 
osseous system
osseous systemosseous system
osseous system
 
Blood pressure mechanism
Blood pressure mechanismBlood pressure mechanism
Blood pressure mechanism
 
Blood vessels and circulation
Blood vessels and circulationBlood vessels and circulation
Blood vessels and circulation
 
Tissues epi and con
Tissues epi and conTissues epi and con
Tissues epi and con
 
Cell communication
Cell communicationCell communication
Cell communication
 
Cell membrane
Cell membraneCell membrane
Cell membrane
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Atherosclerosis Pathophysiology
Atherosclerosis PathophysiologyAtherosclerosis Pathophysiology
Atherosclerosis Pathophysiology
 
Cell 2
Cell 2Cell 2
Cell 2
 
Cell Organalles
Cell OrganallesCell Organalles
Cell Organalles
 
Introduction and scope of anatomy and physiology
Introduction and scope of anatomy and physiologyIntroduction and scope of anatomy and physiology
Introduction and scope of anatomy and physiology
 
Toxicity testing
Toxicity testingToxicity testing
Toxicity testing
 
Scope of anatomy and physiology
Scope of anatomy and physiologyScope of anatomy and physiology
Scope of anatomy and physiology
 
Atherosclerosis Pathophysiology
Atherosclerosis PathophysiologyAtherosclerosis Pathophysiology
Atherosclerosis Pathophysiology
 
Cell injury pathophysiology
Cell injury pathophysiologyCell injury pathophysiology
Cell injury pathophysiology
 
Pathophysiology of Inflammation
Pathophysiology of InflammationPathophysiology of Inflammation
Pathophysiology of Inflammation
 

Último

How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Último (20)

FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 

screening of anti-fertility agent

  • 1. EVALUTION AND SCREENING OF ANTIFERTILITY AGENT Presented by-Komal Dobariya Department Of Pharmacology MPS-1 L.M College Of Pharmacy
  • 2. EVALUTION METHOD OF ANTIFERTILITY AGENT : 1. Estimation of sex hormones 2. Assessment of sperm viability and morphology 3. Assessment of sperm motility and count 4. Mating trial test 5. Body and sex organ weights 6. Quantification of fructose in seminal vesicle 7. Abortifacient activity (Anti-implantation activity) 8. Post-coital anti-fertility activity (Pre-implantation activity) 9. Effect on estrous cycle 10. Anti-estrogenic activity
  • 3. 11.Anti- gonadotrophic effect 12.Histological analysis 13.Measurement of some biochemical and blood parameters 14.Determination of testicular and serum cholesterol (Chod PAP method) 15.Determination of total protein
  • 4. 1.ESTIMATION OF SEX HORMONES : • Blood samples were collected from rats for estimations of serum levels of sex hormones. • Sera were separated into clean bottles, stored frozen and used within 12 h of preparation for the estimation of testosterone, estrogen level, prolactin, follicle stimulating hormone (FSH) and luteinizing hormone (LH).
  • 5. 2. ASSESSMENT OF SPERM MOTILITY AND COUNT : • Progressive motility was tested immediately. The right caudal epididymis was incised and semen was squeezed on a pre-warmed slide. • Two drops of warm 2.9% sodium citrate was added to semen and mixed by a cover-slip. The percentage of progressive sperm motility was evaluated visually at 400 magnification. • Motility estimates were performed from three different fields in each sample. The mean of the three successive estimations was used as the final motility score. • For sperm count, the left caudal epididymis was incised and semen that oozed was quickly sucked into a red blood pipette to the 0.5 mark, and then diluted with warm normal saline up to the 100 mark. A drop of the semen mixture was placed on the Neuberger counting chamber and viewed under the magnification of ×40. The total numbers of sperm cells were counted and expressed as 106/ml.
  • 6. 3. ASSESSMENT OF SPERM VIABILITY AND MORPHOLOGY : • A viability study (percentage of live spermatozoa) was done using eosin/ligroin stain. A drop of semen was squeezed onto a microscope slide and two drops of the stain were added. • Thin smears were then prepared and observed under a light microscope at 100 magnification. Viable sperm remained colorless while non-viable sperm stained red. • The stained and the unstained sperm cells were counted using 40/100 microscope objectives and an average value for each was recorded from which percentage viability was calculated. • To determine the percentage of morphologically abnormal spermatozoa, the slides stained with eosin–ligroin (5 slides/rat) viewed under a light microscope at 100 magnifications.
  • 7. 4. MATING TRIAL TEST : • Mating trial test of male rats was done, 5 d before the termination of the experiment. • Each male rat was cohabitated overnight with protestors females in a ratio of 1:2 and housed in a single cage. Positive mating was confirmed by presence of sperm and vaginal plug in the vaginal smear the following morning. Each sperm positive female was kept under observation and the resultant pregnancies were noted, when dam gave birth. The following reproductive parameters were then computed:  Mating success % = number mated/number paired × 10;  Fertility success % = number pregnant/number paired × 100;  Fertility index = number pregnant/number mated × 100
  • 8. 5. BODY AND SEX ORGAN WEIGHTS : • The initial and final body weights of the animals were recorded. The testes, epididymides, seminal vesicle and ventral prostate were dissected out, freed from adherent tissues and blood, and weighed to the nearest milligram. • Organ weights were reported as relative weights (organ weight/body weight × 100).
  • 9. 6. QUANTIFICATION OF FRUCTOSE IN SEMINAL VESICLE : • For fructose quantification, seminal vesicular homogenate was prepared at a tissue concentration of 50 mg/ml. • The supernatant (seminal plasma) was deproteinized by adding 50 mL of zinc sulfate and sodium hydroxide to make a total dilution of seminal plasma 1:16, followed by centrifugation at 2500 rpm for 15 min. • For fructose measurement, 200 mL of clear seminal plasma was used and the optical density of standard and samples were measured against blank at 470 nm. • The concentration of fructose was obtained by plotting the value in standard curve and the value expressed in the unit of mmol/mL of seminal plasma.
  • 10. 7. ABORTIFACIENT ACTIVITY (ANTI-IMPLANTATION ACTIVITY) : • The plant extracts were tested in female albino rats for abortifacient activity. The vaginal smears of caged female rats of known fertility were monitored daily. Unstained material was observed under a light microscope. • The proportion among the cells observed was used for the determination of the estrous cycle phases. • Female rats were caged with males of proven fertility in the ratio of 2:1, in the evening of proestrous and examined the following day for the evidence of copulation. • Rats exhibiting thick clumps of spermatozoa in their vaginal smears were separated and that day was designated as day one of pregnancy. These rats were randomly distributed into four groups, a control group and three experimental groups of six animals each. Group I received vehicle only and served as control.
  • 11. • Groups II, III, and IV received different extracts. On the 10th day of pregnancy the animals were laparotomies under light ether anesthesia using sterile conditions. The two horns of uteri were examined to determine the implantation sites. • Thereafter the abdominal wound was sutured in layers. Post operational care was taken to avoid any infection. The extract to be tested were then fed to operated pregnant rats, specified by an intragastric soft rubber catheter from day 11 up to the 15th day of pregnancy. The animals were allowed to go to full term. After delivery the pups were counted and the antifertility activity of extract was evaluated. Litters were examined for any malformation.  Percentage abortifacient activity = number of resorptions/number of corpus luteum × 100
  • 12. 8. POST-COITAL ANTIFERTILITY ACTIVITY (PRE IMPLANTATION ACTIVITY) : • The anti-implantation activity is expressed as the percentage of animals showing absence of implantations in uteri when laparotomised on day 10 of pregnancy. • Vaginal smears from each rat were monitored daily and the rats with normal estrous cycle were selected. Rats found in proestrus phase of cycle were caged with males of proven fertility, in the ratio 2:1 and examined the following morning for evidence of copulation. • Rats exhibiting thick clumps of spermatozoa in their vaginal smears were separated and that day was designated as day 1 of pregnancy and those rats were divided into five groups containing six rats in each group.
  • 13. • The extract was administered from day 1–7 of pregnancy. The powdered drug was also administered from day 1–7 of pregnancy. • Control rats received the vehicle (distilled water). • On day 25, laparotomy was performed under light ether anesthesia and semisterile conditions. The uteri were examined to determine the number of implantation sites and no of corpora luteagraviditis .  Frequency of pre-implantation losses = missing no. of implants(corpora lutea implants) × 100. no. of corpora lutea
  • 14. 9. EFFECT ON ESTROUS CYCLE : • The female animals were artificially brought into estrus phase (heat) by administering either suspension of ethinyl estradiol orally at the dose of 100 mg/animal 48 h prior to the pairing and S.c. administration of progesterone at the dose of 1 mg/animal 6 h before the experiment or alternatively by the sequential administration of estradiol benzoate (10 mg/100 g body weight) and progesterone (0.5 mg/100 g body weight) through subcutaneous injections, 48 and 4 h respectively. • Estrous cycle was determined between 8 am and 10 am using vaginal smear method.
  • 15. • Vaginal secretion was collected with a plastic pipette with 10 mL of normal saline. • The vagina was flushed three times with the pipette and the vaginal fluid was placed on a glass slide. • Different slides were used for each animal. • The unstained secretion was observed under a light microscope. • After confirmation of regular four day cycle for 2 weeks the animals were selected for study and divided into six groups and treated with test drugs. • The effect of test drugs on the estrous cycle was monitored for 28 d .
  • 16. 10. ANTIESTROGENIC ACTIVITY : • All the rats were ovariectomized by the same methods described in previous procedure and the weight of the ovaries were recorded. The ovariectomized rats were randomly taken and divided in thirteen groups. Except control, other groups were administered with different doses of estradiol (0.1 mg/rat and 1.0 mg/rat) and followed by test compounds respectively for 4 consecutive days. • On eleventh day, the rats were anaesthetized using ketamine (60 mg/kg, i.p.) and the remaining right sided ovaries were dissected out from all the animals. • Properly cleaned, dries and their respective weights were recorded.
  • 17. • The ovaries weight variations prior to and after treatment with extracts were calculated. • Percentage inhibition of ovarian weight was calculated using the following equation:  Percentage inhibition in ovarian weight = [1 − (XE − C)]/E− C × 100. - Where, C = mean ovarian weight from rats treated with vehicle, E = estradiol and XE = the mean ovarian weight of rats treated with extract and estradiol
  • 18. 11. ANTIGONADOTROPHIC EFFECT : • Female rats were studied for 5 consecutive normal estrus cycles by vaginal smear method. • The rats were anaesthetized using ketamine (60 mg/kg) pretreated with atropine (1 mg/mL) and left side ovariectomy was performed. • Left ovary was dissected out carefully from surrounding fatty tissue and dried by soaking on filter paper and weighed. • The ovariectomized rats were divided into six groups and treated. • On 12th day after treatment, the remaining right ovaries of all rats properly dissected out using same anesthetic condition. • Cleaned, dried and their respective weights were recorded and percentage increase in ovarian weight compared with weight of the left ovaries were calculated. • Percentage increase in the weights of ovary was calculated using the formula.  Percentage increase in ovarian weight = (weight of right ovary − weight of left ovary)/weight of left ovary × 100.
  • 19. 12. HISTOLOGICAL ANALYSIS : • Testes and uteri were carefully dissected out following abdominal incision from male and female rats respectively and fixed in 10% normal-saline and processed routinely for paraffin embedding. • Sections of 5 mm from both were obtained with rotary microtome, stained with Hematoxylin and Eosin Stalin (H/E) respectively and observed under a light microscope .
  • 20. 13. MEASUREMENT OF SOME BIOCHEMICAL AND BLOOD PARAMETERS : • Blood samples were collected from the heart of each rat at the time of scarification into non-heparinized and heparinized tubes. • Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphates, creatinine and urea in addition to red blood cell (RBC) count, total leucocytic count (TLC),hemoglobin (Hb) concentration, packed cell volume (PCV),cholesterol and total proteins were determined by standard methods .
  • 21. 14. DETERMINATION OF TESTICULAR AND SERUM CHOLESTEROL (CHOD PAP METHOD) • Cholesterol is the precursor in the synthesis of many physiologically important steroids such as bile acids, steroid hormones and vitamin D and its requirement for normal sexual activity has been well established. • Testicular and serum cholesterol concentrations may be determined by the Chod–PAP method as briefly, 0.02 cm3 of the working reagent and the absorbance of the resulting mixture is read after 5 min at 546 nm .
  • 22. 15. DETERMINATION OF TOTAL PROTEIN : • A timed rate biuret method was used to measure the concentration of total protein in serum or plasma. • Proteins in the sample combined with the reagent producing alkaline copper-protein chelate. • The rate change in absorbance was monitored by a detector at 545 nm. • The observed rate of chelate formation is directly proportional to the total protein concentration in the sample.
  • 23. REFERENCE : • Article journal homepage: www.jadweb.org • http://www.wikipedia .com